Related Experiment Video
Updated: Jun 12, 2026
08:20
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
Blood-stage malaria vaccines - recent progress and future challenges
1The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK. goodmananna@hotmail.com
Annals of Tropical Medicine and Parasitology
|May 29, 2010
Summary
Developing new malaria vaccines targeting blood-stage Plasmodium falciparum is crucial. Research focuses on antigen selection and clinical trial results to combat this deadly disease.
Area of Science:
- Tropical Medicine
- Vaccinology
- Parasitology
Background:
- Plasmodium falciparum malaria poses a significant global health threat, causing up to 1 million deaths annually.
- Progress has been made in vaccines targeting pre-erythrocytic stages, with one nearing licensure.
- A complementary vaccine targeting blood-stage parasites is needed to enhance control measures.
Purpose of the Study:
- To review recent clinical development of blood-stage malaria vaccines.
- To summarize advances in understanding immunity to blood-stage parasites.
- To discuss challenges and progress in vaccine technologies.
Main Methods:
- Review of recent clinical trial data for blood-stage malaria vaccines.
- Analysis of antigen selection methodologies.
- Evaluation of in-vitro assay limitations for vaccine development.
Main Results:
- Significant progress in understanding blood-stage parasite immunity.
- Advances in vaccine technologies over the past decade.
- Insights into the efficacy and limitations of current vaccine candidates.
Conclusions:
- Further development of blood-stage vaccines is scientifically justified.
- Clinical trial outcomes and technological advancements are key to progress.
- Addressing future challenges is essential for effective malaria control.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:51Vaccinations
Overview